![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/tyligand-bioscience-announces-first-patient-dosed-in-phase-12-clinical-trial-of-tsn1611-a-selective-and-orally-bioavailable-kras-g12d-inhibitor-302155057.html
https://www.globenewswire.com/news-release/2021/08/25/2286290/0/en/Context-Therapeutics-and-Tyligand-Bioscience-Reach-ONA-XR-Manufacturing-Optimization-Milestone.html